VanderWalde A, Bellasea SL, Kendra KL, Khushalani NI, et al. Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial. Nat Med 2023 Aug 17. doi: 10.1038/s41591-023-02498.
PMID: 37592104